The MoU signing between the Can Tho People’s Committee and AstraZeneca Vietnam Co. Ltd on November 14 (Photo: VNA)Can Tho (VNA) – The People’s Committee of the
Mekong Delta city of Can Tho on November 14 signed a memorandum of
understanding (MoU) with AstraZeneca Vietnam Co. Ltd. on cooperation in
innovation in the healthcare sector.
According to Tran Viet Truong, Chairman of the Can Tho
People’s Committee, the partnership is expected to help promote
innovation in particular healthcare areas, including disease prevention and
control, medical and biological research, and human resources training. It will also increase the access to new medicines and vaccines in Can Tho and the Mekong
Delta region.
In the future, the two sides will jointly conduct a number
of programmes in respiratory health, as well as those of cardiovascular, kidney, metabolic, tumor
and digestive health care, he said.
Hoang Quoc Cuong, Director of the city Department of Health, said that the Can Tho University of Medicine and Pharmacy, which trains more than
2,000 doctors and medical staff each year for the Mekong Delta region, is well positioned for to build an innovative healthcare centre in Can Tho. The centre will conduct in-depth research and train
high-quality human resources for the with the engagement of
foreign experts.
Cuong said that currently, 60% of patients in Can Tho
hospitals are from Mekong Delta localities, or about 12 million people of the
total 20 million in the region.
Under the MoU, AstraZeneca Vietnam will work with Can Tho to
give cancer screening to 10,000 people in the region where the rate of pulmonary
tuberculosis is highest in the country.
Cuong said he hopes that in the coming time, the two sides
will expand screening for cancers of the liver, breast, cervix, and thyroid, while
strengthening the application of artificial intelligence in image diagnosis.
Nitin Kapoor, Chairman and General Director of AstraZeneca
Vietnam, pledged that the firm will strengthen cooperation with Can Tho in
promoting innovation in the medical field, providing solutions and initiatives
related to clinical trials, health examination and treatment, as well as in increasing the application of AI in the screening of lung cancer, asthma, and chronic
pulmonary embolism.
The firm also commits to joining hands in environmental
protection and sustainable development in the globe, he said, noting that it is
implementing a 50-million-USD package to reduce carbon emissions in Vietnam.
Currently, AstraZeneca runs 20
centres around the world./.
Source: VietnamPlus
